Exhale

The official blog of the Lung Institute.

How Pneumonia Affects COPD

25 Mar 2016
| Under COPD, Lung Disease, Medical, Related Conditions | Posted by | 5 Comments
How Pneumonia Affects COPD

Pneumonia and COPD can be a deadly mix. Find out why.

While we’ve all experienced the symptoms of a flu or a cold–runny nose, nasal congestion and fits of coughing. Most of us have been fortunate enough to avoid a more serious form of respiratory infection: pneumonia. For those suffering from chronic obstructive pulmonary disease (COPD), pneumonia can be devastating to an already weakened respiratory system.

With your health in mind, the Lung Institute is here to keep you informed on How Pneumonia Affects COPD and how to maintain respiratory health.

Causes

How Pneumonia Affects COPD

Most common when the lungs are already weakened, pneumonia thrives under conditions that typically promote the flu or common colds. Pneumonia can strike at any age and arises from viruses, bacteria, inhaled particles, liquids or fungi. The 2002 issue of American Family Physician states that bacterial infections such as Streptococcus pneumonia and haemophilus influenza cause 70 to 75 percent of COPD exacerbations.

Signs and Symptoms

How Pneumonia Affects COPD

The difficulty in recognizing and diagnosing pneumonia in patients with COPD (particularly in its later stages) is due to the similarity of symptoms between the two conditions.

COPD Symptoms

  • Cough
  • Shortness of breath
  • Excessive sputum
  • Wheezing
  • Chest tightness

Pneumonia

  • Cough
  • Shortness of breath
  • Excessive sputum
  • Wheezing
  • Chest tightness
  • High fever
  • Chills and shaking
  • Chest pain when coughing or breathing

Common in COPD exacerbations and pneumonia

  • Inability to speak due to a shortness of breath
  • Change in color of mucus to green, tan, yellow, or bloody
  • High fever
  • Lack of relief from prescription COPD medications

Risks

How Pneumonia Affects COPD

For people with COPD and other lung diseases, there is an inherently higher risk of not only developing pneumonia, but also suffering serious and life-threatening exacerbations and complications. The relationship between these two conditions greatly impact each other, making symptoms more severe and dangerous for the patient.

The damage from pneumonia and COPD can include inflammation that limits your airflow and causes irreversible damage to your lung tissue, with the most serious complication being respiratory failure.  Today, acute respiratory failure is one of the leading causes of concerns when a COPD patient develops pneumonia.

How to Prevent Pneumonia

How Pneumonia Affects COPD

Get a flu shot. The flu shot reduces the risk of pneumonia since many people develop pneumonia after having the flu. Keep yourself clean by washing your hands, and stay away from those who are sick. It’s also been recommended to exercise and maintain a healthy diet. This will improve your immune system, lower your risk of complications, keep your COPD symptoms minimized and reduce your risk of exacerbations.

Treatment Tips and Cellular Therapy

To avoid the complications of pneumonia and COPD, call your healthcare provider to get an x-ray. Pneumonia thrives within lungs of poor health. To promote healing within your lungs, cellular therapy may be beneficial.

If you’re looking to take control of your health, don’t wait. If you or a loved one suffers from COPD or another lung disease, the Lung Institute may be able to help with a variety of cellular treatment options. Contact us at (800) 729-3065 today to find out if you qualify for cellular therapy.

Looking for more information on How Pneumonia Affects COPD? We want to hear from you. Share your thoughts and comments on How Pneumonia Affects COPD below.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.